Related Research Articles
The Emory University School of Medicine is the graduate medical school of Emory University and a component of Emory’s Robert W. Woodruff Health Sciences Center. Emory University School of Medicine traces its origins back to 1915 when the Atlanta Medical College, the Southern Medical College (1878), and the Atlanta School of Medicine merged.
Harvey James Alter is an American medical researcher, virologist, physician and Nobel Prize laureate, who is best known for his work that led to the discovery of the hepatitis C virus. Alter is the former chief of the infectious disease section and the associate director for research of the Department of Transfusion Medicine at the Warren Grant Magnuson Clinical Center in the National Institutes of Health (NIH) in Bethesda, Maryland. In the mid-1970s, Alter and his research team demonstrated that most post-transfusion hepatitis cases were not due to hepatitis A or hepatitis B viruses. Working independently, Alter and Edward Tabor, a scientist at the U.S. Food and Drug Administration, proved through transmission studies in chimpanzees that a new form of hepatitis, initially called "non-A, non-B hepatitis" caused the infections, and that the causative agent was probably a virus. This work eventually led to the discovery of the hepatitis C virus in 1988, for which he shared the Nobel Prize in Physiology or Medicine in 2020 along with Michael Houghton and Charles M. Rice.
Peter George Traber is an American pharmaceutical company executive. He is the Chief Medical Officer for Selecta Biosciences. https://selectabio.com/ He has been the president and chief executive officer of Baylor College of Medicine (BCM) and the John and Clara Whitmore Professor of Medicine. Traber succeeded Ralph Feigin to become the fourth president of BCM in March 2003, and was president until November 2008. Prior to joining Baylor, he served as Senior Vice President for Clinical Development & Medical Affairs and Chief Medical Officer at GlaxoSmithKline. Prior to that, Traber held positions as Chief Executive Officer of the University of Pennsylvania Health System and interim Dean, Chair of the Department of Internal Medicine for the University of Pennsylvania School of Medicine, Chief of Gastroenterology at the University of Pennsylvania School of Medicine, and faculty member at the University of Michigan School of Medicine. He received his undergraduate degree B.S. in Chemical Engineering at the University of Michigan in 1977, his M.D. from Wayne State Medical School in Michigan in 1981, and he trained as a gastroenterologist, after completing an internal medicine residency at Northwestern University School of Medicine in Chicago.
The Lewis Katz School of Medicine at Temple University (LKSOM), located on the Health Science Campus of Temple University in Philadelphia, Pennsylvania. It is one of seven schools of medicine in Pennsylvania that confers the Doctor of Medicine degree. It also confers Ph.D and M.S. degrees in biomedical science, and offers a Narrative Medicine program.
Ralph Snyderman is a Chancellor Emeritus at Duke University, James B. Duke Professor of Medicine, and Executive Director of the Duke Center for Personalized Health Care. He served as chancellor for health affairs and dean of the School of Medicine from 1989 to July 2004. Under his leadership, Duke University created the Duke University Health System (DUHS) to develop and operate a comprehensive health delivery system, and he was its founding President and Chief Executive Officer. DUHS, with its practice networks, ambulatory care centers, home health services, community hospitals, university hospital, and satellite collaborations demonstrated the power of academic medicine to deliver the best of care to broad communities. Snyderman helped lead the creation of the largest academic clinical research organization worldwide. During his tenure, Duke University Hospital was ranked 6th overall in the nation and its medical school ranked 4th. Snyderman is a leader in the conception and development of personalized health care, an evolving model of national health care delivery. He has articulated the need to move the current focus of health care from the treatment of disease-events to personalized, predictive, preventive, and participatory care that is focused on the patient. As Senior Vice-President at Genentech, he led the development of powerful new molecular biology therapeutics. Ralph Snyderman was the recipient of the 2012 David E. Rogers Award from the Association of American Medical Colleges which recognized him as "The Father of Personalized Medicine." He is a member of the Association of American Medical Colleges, Association of American Physicians, American Academy of Arts & Sciences, and the National Academy of Medicine.
Melvyn Rubenfire is a cardiologist in the University of Michigan Health System, as well as a professor in the department of internal medicine. He is also director of the preventive cardiology department.
Sir John Stewart Savill, FRS, FMedSci is the Chief Executive of the Medical Research Council (MRC) in the UK and the Head of the College of Medicine and Veterinary Medicine and a Vice Principal of the University of Edinburgh.
Ajit Varki is a physician-scientist who is distinguished professor of medicine and cellular and molecular medicine, founding co-director of the Glycobiology Research and Training Center at the University of California, San Diego (UCSD), and founding co-director of the UCSD/Salk Center for Academic Research and Training in Anthropogeny (CARTA). He is also executive editor of the textbook Essentials of Glycobiology and distinguished visiting professor at the Indian Institute of Technology in Madras and the National Center for Biological Sciences in Bangalore. He is a specialist advisor to the Human Gene Nomenclature Committee.
William Shainline Middleton, M.D., M.A.C.P. was a prestigious American internist and military physician. He was one of the founders of the American Board of Internal Medicine and its first Secretary-Treasurer. Middleton was also the second Dean of the University of Wisconsin Medical School.
JeffreyFlier is an American physician, endocrinologist; widely cited scientist; the Higginson Professor of Medicine and Physiology at Harvard Medical School; and a Distinguished Service Professor at the same institution. He was the 21st Dean of the Faculty of Medicine at Harvard University from 2007 to 2016.
Dr. Manuel Martínez Maldonado, MD; MACP, an internist and nephrologist, administrator, educator, poet and author, has authored numerous scientific publications and edited several books. His research interests are the regulation of body fluids and the pathophysiology of blood pressure and its effects on the kidneys. He also focuses on the renin angiotensin system, a hormone system that helps regulate long-term blood pressure and blood volume in the body and which is controlled primarily by the kidneys. His clinical research has included polycycstic kidney disease, renal stones and hypercalcemia. Martinez-Maldonado has occupied numerous positions, including Vice President for Research at Oregon Health and Sciences University (1998-2000), President and Dean of the Ponce School of Medicine (2000–2006). He was the executive vice president for research at the University of Louisville from 2000 to 2009.
Walter "Wally" J. Curran, Jr. is an American radiation oncologist specializing in the treatment of malignant brain tumors and locally advanced lung cancer.
Roderic Ivan Pettigrew is an American physicist, engineer, and physician who is CEO of EnHealth and Executive Dean for EnMed at Texas A&M University. From 2002-November 2017, he was the founding director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at the National Institutes of Health (NIH). He is a pioneer and world expert in cardiovascular magnetic resonance imaging (MRI).
Michael Johns is an American physician. He is a professor in both public health and medicine at E. He is emeritus executive vice president for health affairs at Emory as well as emeritus president, CEO, and chairman of the board of Emory Healthcare. He also served as Emory University's fifth chancellor.
David Goltzman is an endocrinologist, Professor of Medicine and Physiology, and A.G. Massabki Chair in Medicine at McGill University in Montreal, Quebec, Canada. He has been the Director of the Centre for Bone and Periodontal Research and also holds the position of Senior Scientist at the McGill University Health Centre Research Institute in the Metabolic Disorders and Complications Program.
Rexford Sefah Ahima is a professor of medicine, Public Health and Nursing; Bloomberg Distinguished Professor of Diabetes at the Johns Hopkins Medical School; and the Director of the Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University School of Medicine. Ahima's research focuses on central and peripheral actions of adipocyte hormones in energy homeostasis, and glucose and lipid metabolism.
Mark Edwin Silverman MD MACP FACC, was an American cardiologist, medical historian, medical educator and author of more than 200 medical articles and a number of books, who founded the cardiology program at Piedmont Hospital in Atlanta, Georgia.
Louis Harry Newburgh was an American physician and medical educator. He spent most of his career teaching and researching at the University of Michigan. Newburgh was involved in many early experiments and discoveries with obesity and renal diseases. He made significant contributions to the field with his level of meticulousness and detail to the scientific method.
C. William Hanson, III is an American internist, anesthesiologist and intensivist as well as an academic, author and researcher. He is a Professor of Anesthesiology and Critical Care, Surgery and Internal Medicine at the Hospital of University of Pennsylvania and Professor of Computer and Information Science in the School of Engineering and Applied Science at the University of Pennsylvania. He is also the Chief Medical Information Officer of the University of Pennsylvania Health System.
Herbert "Bert" Lancashire DuPont is an American physician, medical school professor, and medical researcher, specializing in infectious diseases.
References
- 1 2 3 Holmes, E. W. (1 October 2005). "Of rice and men: Bill Kelley's next generation". Journal of Clinical Investigation. 115 (10): 2948–2952. doi:10.1172/JCI26871.
- ↑ Who, Marquis Who's. "William N. Kelley, MD, MACP, Recognized for Excellence in Medicine". www.prnewswire.com.
- ↑ "Kelley Out". The Pennsylvania Gazette. 2 March 2000.
- ↑ Kelley, William N. (1 April 2008). "ASCI: reflections on the first 100 years and a proposal for the next". Journal of Clinical Investigation. 118 (4): 1217–1219. doi:10.1172/JCI34652.